InvestorsHub Logo
Followers 6
Posts 216
Boards Moderated 0
Alias Born 05/19/2004

Re: DeepDive post# 751

Monday, 11/20/2017 11:11:18 AM

Monday, November 20, 2017 11:11:18 AM

Post# of 1450
I fail to see how OpRegen can be the "nearest catalyst"?? I'm not going to rehash the last conference call, but it seems the opening comments clearly pointed to the likelihood of Renevia being the lead possibility to affect the share price.

For that matter if the Q1/18 results from AST's spinal study were to be positive and gain more media coverage...and RMAT boost to approval, that could be a tremendous boost to both AST and BTX.

If I'm missing something about OpRegen's likely path to being a near term catalyst, please explain.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News